\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ complaints\\ and\\ no\\ laboratory\\ abnormalities\\.\ \(0\)\
\-\ no\\ specific\\ treatment\\ was\\ undertaken\\,\\ as\\ the\\ patient\\ was\\ asymptomatic\\ and\\ this\\ was\\ considered\\ an\\ incidental\\ finding\\.\ \(0\)\
\-\ small\\ focal\\ area\\ of\\ thickening\\ in\\ the\\ non\\-dependent\\ portion\\ of\\ the\\ gallbladder\\ wall\\ with\\ a\\ bright\\ echogenic\\ focus\\ and\\ a\\ distal\\ comet\\-tail\\ artifact\\.\ \(0\)\
\-\ adenomyomatosis\ \(9\)\
\-\ focal\\ gallbladder\\ wall\\ thickening\\:\ \(0\)\
\-\ \\â\\€\\¢benign\\ conditions\ \(0\)\
\-\ \\Â\\»adenomyomatosis\ \(0\)\
\-\ \\Â\\»polyps\ \(0\)\
\-\ \\Â\\»other\\ benign\\ tumors\\ \\(adenoma\\,\\ cystadenoma\\)\ \(0\)\
\-\ \\â\\€\\¢malignancy\ \(0\)\
\-\ \\Â\\»gallbladder\\ adenocarcinoma\ \(0\)\
\-\ \\Â\\»cholangiocarcinoma\ \(1\)\
\-\ \\Â\\»hepatocellular\\ carcinoma\ \(1\)\
\-\ \\Â\\»metastatic\\ cancer\ \(1\)\
\-\ 61\\ yo\\ african\\ american\\ male\\ presenting\\ for\\ follow\\-up\\ evaluation\\ of\\ portal\\ hypertension\\.\ \(0\)\
\-\ comet\\ tail\\ artifact\\ is\\ caused\\ by\\ reverberation\\ of\\ the\\ ultrasound\\ beam\\ off\\ cholesterol\\ crystals\\ trapped\\ within\\ rokitansky\\-aschoff\\ sinused\\ in\\ the\\ gallbladder\\ wall\\.\\ \\ it\\ is\\ highly\\ specfic\\ for\\ adenomyomatosis\\ and\\ confirmed\\ the\\ diagnosis\\ in\\ this\\ case\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adenomyomatosis\\:\\ 0\\.3686115773630581\ \(0\)\
\-\ gallbladder\\:\\ 0\\.34907386665010387\ \(0\)\
\-\ comet\\:\\ 0\\.25399890892163257\ \(0\)\
\-\ tail\\:\\ 0\\.19264558373030177\ \(0\)\
\-\ artifact\\:\\ 0\\.1887279510337174\ \(0\)\
\-\ wall\\:\\ 0\\.17823087681006308\ \(0\)\
\-\ sinused\\:\\ 0\\.156186397761154\ \(0\)\
\-\ specfic\\:\\ 0\\.156186397761154\ \(0\)\
\-\ reverberation\\:\\ 0\\.14924444124892866\ \(0\)\
\-\ benign\\:\\ 0\\.1341774964023655\ \(0\)\
\-\ thickening\\:\\ 0\\.13288519425169978\ \(0\)\
\-\ undertaken\\:\\ 0\\.12168930080941194\ \(0\)\
\-\ crystals\\:\\ 0\\.12168930080941194\ \(0\)\
\-\ trapped\\:\\ 0\\.12168930080941194\ \(0\)\
\-\ the\\:\\ 0\\.11692534057171487\ \(0\)\
\-\ focal\\:\\ 0\\.11683668043800782\ \(0\)\
\-\ beam\\:\\ 0\\.11437104406425189\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.10871698559427392\ \(0\)\
\-\ cholesterol\\:\\ 0\\.1081901449068709\ \(0\)\
\-\ polyps\\:\\ 0\\.10533001670414538\ \(0\)\
\-\ was\\:\\ 0\\.10211087442821651\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.10040462017465072\ \(0\)\
\-\ 61\\:\\ 0\\.099135819704246\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.09883278575125776\ \(0\)\
\-\ no\\:\\ 0\\.0952779086851093\ \(0\)\
\-\ portal\\:\\ 0\\.09346266366242537\ \(0\)\
\-\ echogenic\\:\\ 0\\.08955465381421805\ \(0\)\
\-\ conditions\\:\\ 0\\.08920876384040057\ \(0\)\
\-\ bright\\:\\ 0\\.08903840451062435\ \(0\)\
\-\ african\\:\\ 0\\.0882111435319631\ \(0\)\
\-\ highly\\:\\ 0\\.08742201900463333\ \(0\)\
\-\ american\\:\\ 0\\.08332617434446793\ \(0\)\
\-\ focus\\:\\ 0\\.08272956445461595\ \(0\)\
\-\ off\\:\\ 0\\.08159531062070535\ \(0\)\
\-\ and\\:\\ 0\\.08072448648234282\ \(0\)\
\-\ complaints\\:\\ 0\\.08042872520842091\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.07982439289157182\ \(0\)\
\-\ caused\\:\\ 0\\.0783099501675699\ \(0\)\
\-\ adenoma\\:\\ 0\\.07786290201833758\ \(0\)\
\-\ presenting\\:\\ 0\\.07650607579422394\ \(0\)\
\-\ of\\:\\ 0\\.07644984598618569\ \(0\)\
\-\ considered\\:\\ 0\\.07610321082146523\ \(0\)\
\-\ hypertension\\:\\ 0\\.07472667743845862\ \(0\)\
\-\ specific\\:\\ 0\\.07400720303314713\ \(0\)\
\-\ in\\:\\ 0\\.0728870875859944\ \(0\)\
\-\ incidental\\:\\ 0\\.07239462641958155\ \(0\)\
\-\ confirmed\\:\\ 0\\.07201414473067741\ \(0\)\
\-\ tumors\\:\\ 0\\.07182702842686645\ \(0\)\
\-\ laboratory\\:\\ 0\\.07092094550611222\ \(0\)\
\-\ abnormalities\\:\\ 0\\.07074534426027267\ \(0\)\
\-\ portion\\:\\ 0\\.06983806066828951\ \(0\)\
\-\ this\\:\\ 0\\.06711839036815963\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.06648795071894553\ \(0\)\
\-\ cancer\\:\\ 0\\.06505129624345969\ \(0\)\
\-\ finding\\:\\ 0\\.06419608779349625\ \(0\)\
\-\ area\\:\\ 0\\.06326831384510608\ \(0\)\
\-\ yo\\:\\ 0\\.061015083337626445\ \(0\)\
\-\ ultrasound\\:\\ 0\\.06024112234842039\ \(0\)\
\-\ evaluation\\:\\ 0\\.05956113880866455\ \(0\)\
\-\ for\\:\\ 0\\.0592025694338404\ \(0\)\
\-\ carcinoma\\:\\ 0\\.05841834021900391\ \(0\)\
\-\ distal\\:\\ 0\\.05674535640896793\ \(0\)\
\-\ metastatic\\:\\ 0\\.0535639557008168\ \(0\)\
\-\ is\\:\\ 0\\.053492036939597525\ \(0\)\
\-\ other\\:\\ 0\\.05071861315773841\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05062845512221622\ \(0\)\
\-\ small\\:\\ 0\\.05037850949511849\ \(0\)\
\-\ it\\:\\ 0\\.04999296467697983\ \(0\)\
\-\ case\\:\\ 0\\.049065457329410006\ \(0\)\
\-\ treatment\\:\\ 0\\.04652266463752181\ \(0\)\
\-\ within\\:\\ 0\\.044981142060972895\ \(0\)\
\-\ male\\:\\ 0\\.04348388119929778\ \(0\)\
\-\ by\\:\\ 0\\.04147390493954063\ \(0\)\
\-\ as\\:\\ 0\\.03923519547732019\ \(0\)\
\-\ an\\:\\ 0\\.03734648147291553\ \(0\)\
\-\ patient\\:\\ 0\\.03176527775860492\ \(0\)\
\-\ with\\:\\ 0\\.019123881187736363\ \(0\)\
